sorry a third point.That the "general" label should remove the issues that arose with the previous PHN trial.
Ann: FDA meeting provides guidance for TPM/Oxymorphone patch, page-7
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $6 | 1.963K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 51 | 93002619 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 60312650 | 22 |
View Market Depth
| Last trade - 09.59am 23/08/2024 (20 minute delay) ? |
| AVE (ASX) Chart |